Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 80

Telerehabilitation to boost arm recovery after stroke in Brazil

Official title: Telerehabilitation and Biomarkers of Functional Recovery After Stroke in Brazil: TR-BR-1 Clinical Trial

Run by University of Sao Paulo · NCT07646522 · Data updated 2026-11-12

In people who recently had a stroke, this study tests whether adding structured arm-focused telerehabilitation to usual care helps improve arm function compared with usual care alone.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (Ribeirão Preto, São Paulo)
StatusRecruiting
StartedJune 12, 2026
Main results expectedSeptember 15, 2027
Study endsFebruary 29, 2028
Registry record updatedJune 16, 2026
Trial IDNCT07646522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with ischemic stroke 120±30 days prior and measurable upper-extremity impairment.

Probably not a fit

Patients with conditions or factors that prevent consistent participation or highly severe impairment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a phase II, two-arm randomized trial in Brazil. It compares telerehabilitation plus usual care to usual care alone for improving upper-extremity function after stroke. The primary outcome is the ARAT score, with secondary measures including feasibility, safety, and intervention-related outcomes, plus neuroimaging and neurophysiological assessments. The study plans 20 participants over about 4 months, with 6 in-person visits and 36 telerehabilitation sessions delivered over six weeks.

Why it matters

Potential benefit: If successful, participants could experience greater arm recovery and reduced disability after stroke.

How similar studies have gone: Prior small studies suggest telerehabilitation can support arm recovery, and this trial aims to provide context in Brazil.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-80 years at the time of randomization.
2. The index stroke was radiologically verified, due to ischemia, and had time of onset 120±30 days prior to randomization.
3. The stroke caused upper extremity deficits as defined by Action Research.
4. Arm Test score 18-44 (out of 57) at Baseline Visit.
5. Box \& Block Test score with affected arm is ≥1 block in 60 seconds at Baseline Visit.
6. Able to successfully perform all 3 rehabilitation exercise test examples (simple commands) at Baseline Visit.
7. Informed consent and behavioral contract signed by the subject (i.e., no surrogate consent).

Exclusion Criteria:

1. A major, active, coexistent neurological, psychiatric, or medical disease that reduces the likelihood that a subject will be able to comply with all study procedures.
2. Unable or unwilling to perform study procedures/therapy, or expectation of noncompliance with study procedures/therapy, or expectation that subject cannot participate in all study visits.
3. A diagnosis (apart from the index stroke) that substantially affects paretic arm function.
4. Severe depression, defined as Geriatric Depression Scale Score \>10/15 at Baseline Visit.
5. Significant cognitive impairment, defined as Montreal Cognitive Assessment \[a lower score can be permitted at the discretion of the PI\].
6. Deficits in communication that interfere with reasonable study participation.
7. Severe UE spasticity, defined as presence of contracture or modified Ashworth Scale score=4 in either biceps or pectoralis.
8. Modified Rankin Scale score \>2 prior to the index stroke.
9. A new symptomatic stroke has occurred since the index stroke, or a separate stroke occurred within 30 days prior to the index stroke.
10. Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye.
11. Life expectancy \< 9 months
12. Pregnancy; women of child-bearing potential must have a negative pregnancy test.
13. Botulinum toxin to the paretic arm: received in the prior 3 months or expected by the 1-Month Visit.
14. Concurrent enrollment in another therapy-based investigational study where the duration of the investigational therapy's activity is likely to occur during the subject's participation in the study.
15. Subject lacks sufficient Portuguese to comply with study procedures and TR instructions.
16. Contraindication to MRI.
17. Contraindication to TMS.
18. Box and Block Test score of ≥30 blocks with the unaffected arm within 60 seconds at Baseline Visit;
19. Spatial neglect interfering with reasonable participation in the study;
20. On isolation precautions, e.g., due to active COVID-19.
21. Expectation that participant will not have a single domicile address during the 6 weeks of therapy.
22. Distance from the participant's home to the study site greater than 120 km \[this can be waived at the discretion of the PI\].

22\. Availability of a 2 m² space for a table and chair setup.

Where it's running

  • Ribeirão Preto Medical School, University of São Paulo
    Ribeirão Preto, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Taiza G. S. Edwards, PhD — University of Sao Paulo
  • Study coordinator: Taiza G. S. Edwards, PhD
  • Email: trbr1@usp.br
  • Phone: +5516-36021202

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.